Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul-Aug;44(4):630-664.
doi: 10.1002/mas.21912. Epub 2024 Nov 11.

Mass Spectrometry Advances in Analysis of Glioblastoma

Sofian Al Shboul  1 , Ashita Singh  2 , Renata Kobetic  3 , David R Goodlett  4 , Paul M Brennan  5 , Ted Hupp  2 , Irena Dapic  3
Affiliations
Review

Mass Spectrometry Advances in Analysis of Glioblastoma

Sofian Al Shboul et al. Mass Spectrom Rev. 2025 Jul-Aug.

Abstract

Some cancers such as glioblastoma (GBM), show minimal response to medical interventions, often only capable of mitigating tumor growth or alleviating symptoms. High metabolic activity in the tumor microenvironment marked by immune responses and hypoxia, is a crucial factor driving tumor progression. The many developments in mass spectrometry (MS) over the last decades have provided a pivotal tool for studying proteins, along with their posttranslational modifications. It is known that the proteomic landscape of GBM comprises a wide range of proteins involved in cell proliferation, survival, migration, and immune evasion. Combination of MS imaging and microscopy has potential to reveal the spatial and molecular characteristics of pathological tissue sections. Moreover, integration of MS in the surgical process in form of techniques such as DESI-MS or rapid evaporative ionization MS has been shown as an effective tool for rapid measurement of metabolite profiles, providing detailed information within seconds. In immunotherapy-related research, MS plays an indispensable role in detection and targeting of cancer antigens which serve as a base for antigen-specific therapies. In this review, we aim to provide detailed information on molecular profile in GBM and to discuss recent MS advances and their clinical benefits for targeting this aggressive disease.

Keywords: glioblastoma; glycans; lipids; mass spectrometry; proteomics; tissues.

PubMed Disclaimer

References

    1. Abelin, J. G., P. D. Trantham, S. A. Penny, et al. 2015. “Complementary IMAC Enrichment Methods for HLA‐Associated Phosphopeptide Identification by Mass Spectrometry.” Nature Protocols 10, no. 9: 1308–1318. https://doi.org/10.1038/nprot.2015.086.
    1. Aboud, O., Y. A. Liu, O. Fiehn, et al. 2023. “Application of Machine Learning to Metabolomic Profile Characterization in Glioblastoma Patients Undergoing Concurrent Chemoradiation.” Metabolites 13, no. 2: 299. https://doi.org/10.3390/metabo13020299.
    1. Abuhusain, H. J., A. Matin, Q. Qiao, et al. 2013. “A Metabolic Shift Favoring Sphingosine 1‐Phosphate at the Expense of Ceramide Controls Glioblastoma Angiogenesis.” Journal of Biological Chemistry 288: 37355–37364.
    1. Alfaro, C. M., V. Pirro, M. F. Keating, E. M. Hattab, R. G. Cooks, and A. A. Cohen‐Gadol. 2020. “Intraoperative Assessment of Isocitrate Dehydrogenase Mutation Status in Human Gliomas Using Desorption Electrospray Ionization‐Mass Spectrometry.” Journal of Neurosurgery 132: 180–187.
    1. Al Shboul, S., S. Boyle, A. Singh, et al. 2024. “Fish Analysis Reveals CDKN2A and IFNA14 Co‐Deletion Is Heterogeneous and Is a Prominent Feature of Glioblastoma.” Brain Tumor Pathology 41: 4–17.

Substances

LinkOut - more resources